Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 545 entries
View as:

Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02001506 Org: User:
Start: 11/30/12 End: 12/31/15 Due: 12/31/16

Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03896906 Org: User:
Start: 05/08/19 End: 04/07/20 Due: 04/07/21

Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.

Phase: N/A Priority: Normal
NCT ID: NCT03944304 Org: User:
Start: 05/27/19 End: 11/30/25 Due: 11/30/26

Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus

Phase: N/A Priority: Normal
NCT ID: NCT03509701 Org: User:
Start: 05/01/18 End: 04/30/20 Due: 04/30/21

Incidence and Risk Factor of Hydroxychloroquine and Chloroquine Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT02550964 Org: User:
Start: 01/31/14 End: 01/31/19 Due: 01/31/20

Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

Phase: N/A Priority: Normal
NCT ID: NCT02201797 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

FFR and Inducible Myocardial Ischemia During Adenosine Stress Testing

Phase: N/A Priority: Normal
NCT ID: NCT04401657 Org: User:
Start: 05/08/20 End: 03/31/22 Due: 03/31/23

Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC

Phase: N/A Priority: Normal
NCT ID: NCT03156036 Org: User:
Start: 11/30/17 End: 02/02/21 Due: 02/02/22

Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT01446666 Org: User:
Start: 11/30/11 End: 12/31/14 Due: 12/31/15

Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale

Phase: N/A Priority: Normal
NCT ID: NCT04285918 Org: User:
Start: 10/02/19 End: 10/02/24 Due: 10/02/25

Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00336843 Org: User:
Start: 11/30/05 End: 05/31/10 Due: 05/31/11

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Phase: N/A Priority: Normal
NCT ID: NCT01917552 Org: User:
Start: 08/19/13 End: 08/01/26 Due: 08/01/27

Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

Phase: N/A Priority: Normal
NCT ID: NCT02613988 Org: User:
Start: 01/12/20 End: 12/31/25 Due: 12/31/26

TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT03394118 Org: User:
Start: 08/11/17 End: 04/08/21 Due: 04/08/22

The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01178190 Org: User:
Start: 07/31/09 End: 06/30/10 Due: 06/30/11

Feasibility and Accuracy of Core Temperature Measurements Using the Esophageal Temperature Probe Inserted Through the Gastric Lumen of Supraglottic Airway Device in Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT05705206 Org: User:
Start: 03/25/21 End: 03/16/22 Due: 03/16/23

Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00446290 Org: User:
Start: 03/31/06 End: 10/31/07 Due: 10/31/08

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06086665 Org: User:
Start: 12/01/19 End: 10/31/22 Due: 10/31/23

Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01477918 Org: User:
Start: 12/31/11 End: - Due: -

Radical Hysterectomy Followed by Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

Phase: N/A Priority: Normal
NCT ID: NCT01680523 Org: User:
Start: 09/30/12 End: 07/31/20 Due: 07/31/21

Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03665571 Org: User:
Start: 07/31/16 End: 10/31/19 Due: 10/31/20

Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT00689715 Org: User:
Start: 06/30/06 End: 08/31/16 Due: 08/31/17

Newly Designed Fully Covered Metal Stent for the Benign Biliary Stricture

Phase: N/A Priority: Normal
NCT ID: NCT00945516 Org: User:
Start: 01/31/09 End: 05/31/10 Due: 05/31/11

Voriconazole Plasma Level in Intensive Care Unit (ICU) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01185405 Org: User:
Start: 08/31/10 End: 12/31/13 Due: 12/31/14

Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)

Phase: N/A Priority: Normal
NCT ID: NCT02311205 Org: User:
Start: 12/31/14 End: 06/30/18 Due: 06/30/19